[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Chronic Hepatitis B Virus Infection: Developing Drugs for T...[ Price : $8.95]
Federal Register notice: FDA announces a 12/6 public workshop entitled Product Development in Hemophilia.[ Price : $8.95]
FDA approves an AcelRx Pharmaceuticals resubmitted NDA for Dsuvia (sufentanil sublingual tablet, 30 micrograms) for treating moder...[ Price : $8.95]
FDA permits the de novo marketing of two devices that provide real-time location of parathyroid tissue during surgical procedures ...[ Price : $8.95]
FDA classifies as Class 1 a Roche Diagnostics recall of its CoaguChek XS PT Test Strips due to inaccurate International Normalized...[ Price : $8.95]
FDA issues a draft guidance to assist sponsors develop drugs and biologics to treat chronic hepatitis B viral infections.[ Price : $8.95]
FDA warns against using results from many genetic tests to predict how a patient will respond to a specific medication.[ Price : $8.95]
Federal Register notice: FDA classifies the meprobamate test system into Class 2 (special controls).